In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...

Even with the HIV prevention waters now dominated by Gilead Science’s Yeztugo (lenacapavir), Merck & Co. is not afraid to swim deeper in. | Even with the HIV prevention waters now dominated by Gilead ...

Hiding behind numerous disguises, HIV has been evading researchers for years, leaving the search for a vaccine as elusive as the virus itself.

You can notice signs of HIV on the tongue during the early and late stages of the infection with the virus. An acute HIV ...

People living with HIV who have taken highly active antiretroviral therapy can have hyperlipidemia predicted in advance by machine learning.

HIV jab has signed a deal to supply the costly injection at a knock-down price to as many as two million people in poorer countries.

"There is now an urgent need for bolder and more realistic approaches to address HIV transmission among IPT students, similar ...

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the young. New research reveals older adults face comparable or higher ...

While a vaccine to prevent HIV still is needed, some experts say the new shot could be the next best thing.

Sanchez estimates that since the program was launched in 2023, it has led to nearly 7,000 people learning they were living with HIV.The CDC has also said on its website that it cannot continue ...

WASHINGTON (AP) — The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's unclear ...

The minister in the Prime Minister’s Department (Religious Affairs) said 1,091 students from institutions of higher learning ...